From the preventive vaccine for cervical cancer to the first therapy
ever proven to extend the lives
of patients with metastatic melanoma, immunology has already led to major treatment breakthroughs for a
number of cancers.
Furthermore, there is also little question that the vast majority
of conversations, seminars and published papers on the subject have addressed gut microflora purely in terms
of its role in GI health, particularly in reference to the
ever increasing
number of patients who present with issues such as irritable bowel syndrome (IBS), small intestinal bacterial overgrowth (SIBO), and inflammatory bowel disease.
Unfortunately, many facilities fail to put
patients before profits, scaling back staff to skeletal levels even as the demands
of an increasing
number of patients require more help than
ever.